By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health,...
The first patient to receive medical cannabis flower through the NHS has shared how it helped him manage debilitating side-effects of cancer treatment.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid...
A new UK-wide service has launched to support medical cannabis patients who face discrimination.
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
Early research suggests CBG-A could support cardiovascular health and reduce oxidative stress.
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners....
The case highlights the need for clear and consistent guidance on driving when prescribed medical cannabis.
